Globus Medical Enters International Market with ExcelsiusGPS Robotic Guidance and Navigation System

Medical Device Investing

Globus Medical (NYSE:GMED), a leading musculoskeletal solutions company, recently announced the entrance of ExcelsiusGPS, a revolutionary robotic guidance and navigation system, to the international market with system installations completed in several European countries. As quoted in the press release: This past October, the first European Excelsius GPS® procedure was performed at the Metropolitan Hospital in …

Globus Medical (NYSE:GMED), a leading musculoskeletal solutions company, recently announced the entrance of ExcelsiusGPS, a revolutionary robotic guidance and navigation system, to the international market with system installations completed in several European countries.

As quoted in the press release:

This past October, the first European Excelsius GPS® procedure was performed at the Metropolitan Hospital in Neo Faliro, Athens, Greece by Mr. Panagiotis E. Zoumpoulis. Since then, numerous open and minimally invasive spine procedures have been performed at Bonifatius Hospital in Germany and at the Fornaca Clinic in Italy.

“Surgeons and hospital administrators in the United States have shown tremendous levels of interest in ExcelsiusGPS® since it first launched domestically at the end of 2017,” said Dave Demski, Chief Executive Officer at Globus Medical. “Users have realized the system’s ability to help advance patient care and provide tangible benefits for surgeons and their staff. As we begin to scale our efforts abroad, we have seen similar levels of enthusiasm within the international surgeon community and look forward to the continued adoption of ExcelsiusGPS® into these markets.”

Click here to read the full press release.

The Conversation (0)
Ă—